Evaluation of the awareness of novel advanced therapies among family medicine residents in Spain
Metadatos
Afficher la notice complèteAuteur
Sola, Miguel; Sánchez Quevedo, María Del Carmen; Martín Piedra, Miguel Ángel; Carriel Araya, Víctor; Garzón Bello, Ingrid Johanna; Chato Astrain, Jesús; García García, Óscar Darío; Alaminos Mingorance, Miguel; Campos, FernandoEditorial
PLOS
Date
2019-04-03Referencia bibliográfica
Sola M, Sanchez-Quevedo C, Martin- Piedra MA, Carriel V, Garzon I, Chato-Astrain J, et al. (2019) Evaluation of the awareness of novel advanced therapies among family medicine residents in Spain. PLoS ONE 14(4): e0214950.
Patrocinador
This work was supported by CTS-115 (Tissue Engineering Group), Junta de Andalucia.Résumé
Advanced therapies are increasingly demanded by patients with the intent of treating some
incurable conditions. Because family medicine professionals play an important role as
health educators, their residency programs should incorporate new knowledge related
to advanced therapies. To successfully implement these programs, how family medicine
residents perceive these therapies should be investigated. The main components of perception,
i.e. conceptual, procedural and attitudinal, refer to knowledge, skills and feelings,
respectively. We designed a specific questionnaire to assess the components of perceptions of advanced
therapies in 300 medical residents enrolled in the Spanish National Family Medicine Residency
Program. Each component consisted of 4 or 5 topics and each topic contained 6
items. Respondents scored highest in the procedural component (average 4.12±1.00), followed
by the attitudinal (3.94±1.07) and conceptual component (3.04±1.43). Differences
among the three components were statistically significant (p<0.00017). Family medicine
residents perceived that procedures to implement advanced therapies are well established,
especially their application. However, they felt their cognitive background was insufficient to
respond efficiently to the expectations generated by these new therapeutic tools, especially
in the regulatory framework. High awareness of the risks and limitations of these treatments
was reflected by residents’ preference for clinically tested therapies. Although they appropriately
situated treatment with these therapies within hospital care, they associated the biofabrication
of novel products with research centers, although these therapeutic tools can be
produced in different facilities. These results are potentially useful for designing future training programs and health policies
for family medicine residents, and suggest the need to implement specific training programs
in advanced therapies at the conceptual, procedural and attitudinal level.